These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23103220

  • 1. Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
    Jakubovic BD, Wald R, Goldstein MB, Leong-Poi H, Yuen DA, Perl J, Lima JA, Liu JJ, Kirpalani A, Dacouris N, Wald R, Connelly KA, Yan AT.
    Can J Cardiol; 2013 Mar; 29(3):384-90. PubMed ID: 23103220
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.
    Arnold R, Schwendinger D, Jung S, Pohl M, Jung B, Geiger J, Gimpel C.
    Pediatr Nephrol; 2016 Feb; 31(2):255-65. PubMed ID: 26342304
    [Abstract] [Full Text] [Related]

  • 3. Assessment of Left Ventricular Mass and Hypertrophy by Cardiovascular Magnetic Resonance Imaging in Pediatric Hypertension.
    Supe-Markovina K, Nielsen JC, Musani M, Panesar LE, Woroniecki RP.
    J Clin Hypertens (Greenwich); 2016 Oct; 18(10):976-981. PubMed ID: 26988578
    [Abstract] [Full Text] [Related]

  • 4. Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis.
    Armstrong AC, Gjesdal O, Almeida A, Nacif M, Wu C, Bluemke DA, Brumback L, Lima JA.
    Echocardiography; 2014 Oct; 31(1):12-20. PubMed ID: 23930739
    [Abstract] [Full Text] [Related]

  • 5. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
    Patel RK, Oliver S, Mark PB, Powell JR, McQuarrie EP, Traynor JP, Dargie HJ, Jardine AG.
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1477-1483. PubMed ID: 19713289
    [Abstract] [Full Text] [Related]

  • 6. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP, Costabel JP, Asch FM, Sciancalepore A, Kuschnir P, Huguet M, Tobon-Gomez C, Frangi AF, Ronderos R.
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [Abstract] [Full Text] [Related]

  • 7. A comparison of left ventricular mass between two-dimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension.
    Alfakih K, Bloomer T, Bainbridge S, Bainbridge G, Ridgway J, Williams G, Sivananthan M.
    Eur J Radiol; 2004 Nov; 52(2):103-9. PubMed ID: 15489067
    [Abstract] [Full Text] [Related]

  • 8. [Three-dimensional analysis of left ventricular geometry using magnetic resonance imaging: feasibility and comparison with echocardiographic analysis].
    Moriuchi M, Saito S, Kasamaki Y, Komaki K, Kanmatsuse K, Hayasaka K.
    J Cardiol; 2003 Dec; 42(6):249-60. PubMed ID: 14723017
    [Abstract] [Full Text] [Related]

  • 9. Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients.
    Grebe SJ, Malzahn U, Donhauser J, Liu D, Wanner C, Krane V, Hammer F.
    Cardiovasc Ultrasound; 2020 Sep 16; 18(1):39. PubMed ID: 32938484
    [Abstract] [Full Text] [Related]

  • 10. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
    Seo HY, Lee SP, Park JB, Lee JM, Park EA, Chang SA, Kim HK, Park SJ, Lee W, Kim YJ, Lee SC, Park SW, Sohn DW, Choe YH.
    J Am Soc Echocardiogr; 2015 Oct 16; 28(10):1194-1203, e2. PubMed ID: 26194306
    [Abstract] [Full Text] [Related]

  • 11. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahlöf B, Køber L, Wachtell K, Devereux RB.
    Circ Cardiovasc Imaging; 2014 May 16; 7(3):422-9. PubMed ID: 24723582
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
    Ruebner RL, Ng D, Mitsnefes M, Foster BJ, Meyers K, Warady B, Furth SL.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1962-1968. PubMed ID: 27630183
    [Abstract] [Full Text] [Related]

  • 13. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM, Lakdawala NK, Powell AJ, Evans SP, Cirino AL, Orav EJ, MacRae CA, Colan SD, Ho CY.
    Circ Cardiovasc Genet; 2013 Jun 07; 6(3):230-7. PubMed ID: 23690394
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL.
    Int J Cardiovasc Imaging; 2016 Jun 07; 32(6):945-54. PubMed ID: 26896038
    [Abstract] [Full Text] [Related]

  • 15. The impact of change in volume and left-ventricular hypertrophy on left-ventricular mechanical dyssynchrony in children with end-stage renal disease.
    Kobayashi D, Patel SR, Mattoo TK, Valentini RP, Aggarwal S.
    Pediatr Cardiol; 2012 Oct 07; 33(7):1124-30. PubMed ID: 22441563
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease.
    Hazari H, Belenkie I, Kryski A, White JA, Oudit GY, Thompson R, Fung T, Dehar N, Khan A.
    Can J Cardiol; 2018 Aug 07; 34(8):1041-1047. PubMed ID: 29935990
    [Abstract] [Full Text] [Related]

  • 17. Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm.
    Codella NC, Lee HY, Fieno DS, Chen DW, Hurtado-Rua S, Kochar M, Finn JP, Judd R, Goyal P, Schenendorf J, Cham MD, Devereux RB, Prince M, Wang Y, Weinsaft JW.
    Circ Cardiovasc Imaging; 2012 Jan 07; 5(1):137-46. PubMed ID: 22104165
    [Abstract] [Full Text] [Related]

  • 18. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease.
    Cordeiro AC, Lindholm B, Sousa MG, Picotti JC, Nunes GJ, Santana MR, Grimaldi W, Amparo FC, Amodeo C, Carrero JJ.
    J Hypertens; 2014 Feb 07; 32(2):439-45. PubMed ID: 24317549
    [Abstract] [Full Text] [Related]

  • 19. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy.
    Szwejkowski BR, Gandy SJ, Rekhraj S, Houston JG, Lang CC, Morris AD, George J, Struthers AD.
    J Am Coll Cardiol; 2013 Dec 17; 62(24):2284-93. PubMed ID: 23994420
    [Abstract] [Full Text] [Related]

  • 20. Assessment of left-ventricular mass and remodeling in obese adolescents: M-mode, 2D or 3D echocardiography?
    Pacileo G, Castaldi B, Di Salvo G, Limongelli G, Rea A, D'Andrea A, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2013 Feb 17; 14(2):144-9. PubMed ID: 22343263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.